Literature DB >> 33426063

LHPP Inhibits the Proliferation and Metastasis of Renal Cell Carcinoma.

Xiaoting Zhang1, Huaning Kang2, Jing Xiao1, Benyan Shi1, Xiaofeng Li3, Guihong Chen1,2.   

Abstract

Renal cell carcinoma (RCC) is one of the ten most common cancers in the globe. Despite the diagnosis and treatment of renal cell carcinoma that have made great improvements, the morbidity and mortality rates of renal cell carcinoma remain unchanged remarkably. LHPP is a kind of histidine phosphatases, acting as a tumor suppressor in the progression of various cancers. In this study, we found that LHPP was significantly downregulated in RCC tissues and cell lines. Decreased expression of LHPP was closely correlated with tumor size and postoperative metastasis of RCC patients. In addition, overexpression of LHPP inhibited the proliferation and metastasis of RCC. However, suppression of LHPP promoted the proliferation and metastasis of RCC. In conclusion, our results presented the important role of LHPP in the development and progression of RCC.
Copyright © 2020 Xiaoting Zhang et al.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33426063      PMCID: PMC7772040          DOI: 10.1155/2020/7020924

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  15 in total

Review 1.  Systemic Therapy for Metastatic Renal-Cell Carcinoma.

Authors:  Toni K Choueiri; Robert J Motzer
Journal:  N Engl J Med       Date:  2017-01-26       Impact factor: 91.245

2.  The protein histidine phosphatase LHPP is a tumour suppressor.

Authors:  Sravanth K Hindupur; Marco Colombi; Stephen R Fuhs; Matthias S Matter; Yakir Guri; Kevin Adam; Marion Cornu; Salvatore Piscuoglio; Charlotte K Y Ng; Charles Betz; Dritan Liko; Luca Quagliata; Suzette Moes; Paul Jenoe; Luigi M Terracciano; Markus H Heim; Tony Hunter; Michael N Hall
Journal:  Nature       Date:  2018-03-21       Impact factor: 49.962

Review 3.  Systemic therapy in renal cell carcinoma: advancing paradigms.

Authors:  Edwin M Posadas; Robert A Figlin
Journal:  Oncology (Williston Park)       Date:  2012-03       Impact factor: 2.990

4.  LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.

Authors:  Wenyu Sun; Kai Qian; Kai Guo; Lili Chen; Jun Xiang; Duanshu Li; Yi Wu; Qinghai Ji; Tuanqi Sun; Zhuoying Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2020-04-20       Impact factor: 3.848

5.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

6.  Relationship between the LHPP Gene Polymorphism and Resting-State Brain Activity in Major Depressive Disorder.

Authors:  Lingling Cui; Xiaohong Gong; Yanqing Tang; Lingtao Kong; Miao Chang; Haiyang Geng; Ke Xu; Fei Wang
Journal:  Neural Plast       Date:  2016-10-23       Impact factor: 3.599

Review 7.  Renal cell carcinoma: An update for the practicing urologist.

Authors:  Sumanta K Pal; Paulo Bergerot; Robert A Figlin
Journal:  Asian J Urol       Date:  2015-04-16

8.  Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.

Authors:  Zeyu Tian; Tanbo Yu; Hongyan Wei; Ning Ning
Journal:  J Clin Lab Anal       Date:  2019-11-06       Impact factor: 2.352

9.  LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer.

Authors:  Fahong Wu; Yanling Chen; Jinhai Zhu
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

10.  Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.

Authors:  Bin Hou; Wenhan Li; Jianhui Li; Jia Ma; Peng Xia; Zhao Liu; Qingnuo Zeng; Xin Zhang; Dongmin Chang
Journal:  Oncol Rep       Date:  2019-12-20       Impact factor: 3.906

View more
  3 in total

1.  Tumor suppressor LHPP suppresses cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cell lines.

Authors:  Lunkun Ma; Huifang Sun; Xichao Xu; Ying Chen; Lu Zhang; Shun Li; Liling Tang
Journal:  J Physiol Biochem       Date:  2022-07-07       Impact factor: 4.158

Review 2.  The histidine phosphatase LHPP: an emerging player in cancer.

Authors:  Fahong Wu; Hanwei Ma; Xiaoli Wang; Hangzhi Wei; Wei Zhang; Youcheng Zhang
Journal:  Cell Cycle       Date:  2022-03-03       Impact factor: 5.173

3.  Amino Acid Nanofibers Improve Glycemia and Confer Cognitive Therapeutic Efficacy to Bound Insulin.

Authors:  Aejin Lee; McKensie L Mason; Tao Lin; Shashi Bhushan Kumar; Devan Kowdley; Jacob H Leung; Danah Muhanna; Yuan Sun; Joana Ortega-Anaya; Lianbo Yu; Julie Fitzgerald; A Courtney DeVries; Randy J Nelson; Zachary M Weil; Rafael Jiménez-Flores; Jon R Parquette; Ouliana Ziouzenkova
Journal:  Pharmaceutics       Date:  2021-12-29       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.